Human ex vivo skin model with features of psoriatic lesions
CompanyGenoskin, Toulouse, France
The skin model "InflammaSkin" developed by Genoskin represents a T-cell-driven skin inflammation model for psoriasis from epidermis, dermis and fatty tissue. The model has been shown to respond successfully to subcutaneous administration of the biological agent adalimumab.
Evaluation of pharmacological responses to subcutaneous injection of adalimumab in InflammaSkin®, a full-thickness human ex vivo skin model reproducing key features of psoriatic lesions
contact@genoskin.com
Added on: 10-14-2020
[1] https://www.genoskin.com/latest-news-and-data/publications/inflammaskin/[2] https://www.genoskin.com/en/tissue-samples/human-psoriasis-model/